Safety study of GSK4771261 in healthy adults
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This is a Phase 1 trial testing a new investigational drug (GSK4771261) in healthy volunteers to understand how the body processes it and to check for safety. Participation involves receiving the study drug and having blood tests and physical exams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 25 and 55 years old and in good health with no major medical conditions
- Weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, with a healthy BMI (18–28)
- Be of Chinese, Japanese, or White/European ancestry and meet specific residency criteria
- Not be pregnant, breastfeeding, or able to become pregnant
- Not have kidney disease, heart disease, diabetes, thyroid disease, or cancer in the past 5 years
- Not take most medications or supplements (except acetaminophen) for 7 days before and during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests an experimental drug called AZD4248 to see if it's safe for healthy people and for people with chronic kidney disease and type 2 diabetes. It also checks if a home device can accurately measure kidney function.
Hear when a new Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.